U.S. Senate · 117th Congress · S. 2495
Protecting our Pharmaceutical Supply Chain from China Act of 2021
A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Tom CottonR-AR
- Introduced
- July 28, 2021, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (4)
4 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Marsha BlackburnR-TN
- Mike BraunR-IN
- Ted CruzR-TX
- Rick ScottR-FL